摘要
目的观察白三平(孟鲁司特)治疗小儿毛细支气管炎的临床疗效。方法选择2010年3月至2010年7月在江门市中心医院就诊符合病例纳入标准的毛细支气管炎200例,随机分入治疗组与对照组各100例,均给予综合治疗,治疗组在综合治疗的基础上加用白三平4mg/次,1次/d,睡前口服。观察两组的临床症状、体征改善时间和评价两组的临床综合疗效。结果治疗组的临床症状、体征改善时间少于对照组,两组比较差异有统计学意义(P<0.05);而评价两组的临床综合疗效,治疗组也优于对照组,两组比较差异有统计学意义(P<0.05)。结论白三平是治疗婴幼儿急性毛细支气管炎有效的药物,可缩短病程,提高疗效。
Objective To observe the efficacy of montelukast in treating the infants with bronchiolitis.Methods 200cases of bronchiolitis according with internalized standard were randomly divided into the treatment group and the control group,which were found in Jiangmen central hospital from march 2010 to July 2010.All the cases were treated with combined therapy,and the treatment group were treated with montelukast（4mg/time,qd,orally at bedtime） additionally.To observe the duration of the clinical symptoms and signs,and to evaluate of integrated efficacy of the two groups.Result The duration of the clinical symptoms and signs in the treatment group was less than the control group,the difference was statistically significant（P0.05）;and comprehensive evaluation of the clinical efficacy of the two groups,the treatment group is better than the control group,two groups There was significant difference（P0.05）.Conclusion Montelukast is an effective drug in treating the infants with acute bronchiolitis,montelukast can shorten the course and improve the curative effect.
出处
《中国医药指南》
2010年第36期15-17,共3页
Guide of China Medicine
